Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Safety of Intranasal Breast Milk in Hypoxic-ischaemic Encephalopathy

NCT06747260 is registered in ClinicalTrials.gov with Semmelweis University as lead sponsor.

NCT NCT06747260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06747260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Safety of Intranasal Breast Milk in Hypoxic-ischaemic Encephalopathy
Lead sponsor
Semmelweis University
Phase
Phase 1
Overall status
Recruiting
Start date
November 22, 2024
Completion date
January 1, 2030
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain injury, hypoxic ischaemic encephalopathy (hie), hypoxic ischemic encephalopathy of newborn, neonatal encephalopathy, neonatal hypoxic ischemic encephalopathy, perinatal asphyxia, perinatal asphyxia , moderate to severe hie